We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Radiosurgery System Used To Treat Spinal Tumors

By HospiMedica staff writers
Posted on 12 Mar 2007
A new study shows the potential of radiosurgery in improving long-term palliation of pain in patients with spinal metastases, especially those with solitary sites of spine involvement. More...

Researchers at the University of Pittsburgh Medical Center (Pittsburgh, PA, USA) conducted a study on the effectiveness of the CyberKnife robotic radiosurgery system. The study included 500 patients who underwent treatment; ages ranged from 18 to 85 years (mean 56). Lesion location included 73 cervical, 212 thoracic, 112 lumbar, and 103 sacral lesions. The maximum intratumoral dose ranged from 12.5 to 25 Gy (mean 20). Tumor volume ranged from 0.20 to 264 ml (mean 46).
The results showed that long-term pain improvement occurred in 290 of 336 cases (86%). Long-term tumor control was demonstrated in 90% of lesions treated with radiosurgery as a primary treatment modality and in 88% of lesions treated for radiographic tumor progression. Twenty-seven of 32 cases (84%) with a progressive neurologic deficit before treatment experienced at least some clinical improvement. The results of the study were published in the January 15, 2007, issue of the journal Spine.

"We've had tremendous success with the CyberKnife system in treating patients with complex spinal tumors,” said lead author Dr. Peter Gerszten. "The results of our study demonstrate the CyberKnife System's effectiveness in controlling tumor progression and minimizing any associated side effects.”

The CyberKnife robotic radiosurgery system combines continuous image-guidance technology with a compact linear accelerator that has the flexibility to move in three dimensions according to the treatment plan. The system uses the internal anatomy to directly track tumors without the need for external frames or implanted fiducials. The system registers unique non-rigid and bony anatomy landmarks to track, detect, and correct for the movement of the spine in real-time throughout the treatment, allowing doctors to deliver high doses of radiation with sub-millimeter accuracy while avoiding damage to healthy tissue. The system is made by Accuray (Sunnyvale, CA, USA).


Related Links:
University of Pittsburgh Medical Center
Accuray

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.